ADR

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Hepsiburada (D-MARKET Elektronik Hizmetler ve Ticaret Anonim Şirketi a/k/a D-MARKET Electronic Services & Trading) (HEPS) Investors

Friday, October 22, 2021 - 4:30pm

Hepsiburada investors have until December 20, 2021 to file a lead plaintiff motion.

Key Points: 
  • Hepsiburada investors have until December 20, 2021 to file a lead plaintiff motion.
  • Investors suffering losses on their Hepsiburada investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com .
  • On or about July 1, 2021, Hepsiburada completed its IPO, selling approximately 62 million shares for $12.00 per share.
  • On August 26, 2021, Hepsiburada announced its second quarter 2021 financial results, reporting that revenue grew 5.2%.

Motorola Mobility Named "Mobile Security Solution Provider of the Year" in 2021 Mobile Breakthrough Awards Program

Thursday, October 21, 2021 - 3:00pm

LOS ANGELES, Oct. 21, 2021 /PRNewswire-PRWeb/ -- Mobile Breakthrough , a leading independent market intelligence organization that recognizes the top companies, technologies and products in the global wireless and mobile market, today announced that Motorola Mobility, a Lenovo Company , has been selected as winner of the "Mobile Security Solution Provider of the Year" award in the fifth annual Mobile Breakthrough Awards program.

Key Points: 
  • LOS ANGELES, Oct. 21, 2021 /PRNewswire-PRWeb/ -- Mobile Breakthrough , a leading independent market intelligence organization that recognizes the top companies, technologies and products in the global wireless and mobile market, today announced that Motorola Mobility, a Lenovo Company , has been selected as winner of the "Mobile Security Solution Provider of the Year" award in the fifth annual Mobile Breakthrough Awards program.
  • Congratulations to Motorola on being the clear choice for the 'Mobile Security Solution Provider of the Year' award."
  • Motorola Mobility is a wholly owned subsidiary of Lenovo, and is responsible for designing and manufacturing all Moto and Motorola branded mobile handsets and solutions.
  • The Mobile Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough mobile companies and products in categories including Cloud Computing, Mobile Management and Security, Wireless and Broadband, Mobile Analytics, IoT and Smart City technology, WLAN, WiFi and more.

Esper and Lenovo Collaborate on Android Device Deployment in Enterprises

Thursday, October 21, 2021 - 2:05pm

DevOps for Devices leader Esper and Lenovo are teaming up to place Esper software on key models of Lenovo Android tablets and other intelligent business devices.

Key Points: 
  • DevOps for Devices leader Esper and Lenovo are teaming up to place Esper software on key models of Lenovo Android tablets and other intelligent business devices.
  • This collaboration allows enterprises that manage large fleets of devices to focus on their critical line-of-business applications, leaving the device infrastructure and management tasks to Lenovo and Espers joint solution.
  • Their joint solution has provided global customers a more reliable infrastructure to accelerate their device deployment leading to significant revenue growth.
  • Legacy mobile device management (MDM) solutions do not yet support healthcare providers need to deploy and maintain advanced software enterprises.

Lenovo Enhances Deep Partnership With VMware, Introducing New Edge-to-Cloud and AI Solutions

Wednesday, October 20, 2021 - 3:00pm

Additionally, Lenovo highlighted the continued expansion of its Lenovo TruScale TM as-a-Service hybrid cloud solutions.

Key Points: 
  • Additionally, Lenovo highlighted the continued expansion of its Lenovo TruScale TM as-a-Service hybrid cloud solutions.
  • Lenovo unveils the industrys most scalable, vSAN-certified SAP HANA solution for HCI environments with its 8-Socket, ThinkAgile VX Certified Node.
  • Working with SAP and VMware, Lenovo provides a massively scalable SAP HANA certified on VMware vSAN ReadyNode solution.
  • Lenovo delivers an expanded portfolio of ThinkSystem servers, designed for Analytics and AI workloads with NVIDIA AI Enterprise and VMware vSphere 7.

NAM Introduces a Customized Fee Structure for Mass Arbitration Filings in the Employment and Consumer ADR Arenas

Wednesday, October 20, 2021 - 3:00pm

NAM (National Arbitration and Mediation), one of the nations leading providers of Alternative Dispute Resolution (ADR) services, is pleased to announce that we have created a customized fee structure to address issues that have arisen as a result of mass filings of arbitration demands in the Employment and Consumer arenas.

Key Points: 
  • NAM (National Arbitration and Mediation), one of the nations leading providers of Alternative Dispute Resolution (ADR) services, is pleased to announce that we have created a customized fee structure to address issues that have arisen as a result of mass filings of arbitration demands in the Employment and Consumer arenas.
  • In the wake of several recent high-profile arbitrations, the subject of mass arbitration filings continues to draw significant attention and media coverage.
  • To learn more about this program and to listen to an ABA podcast about Mass Arbitration Filings with NAM neutral, Hon.
  • NAM is recognized for its superb customer service, market-leading technology and an exceptional panel of arbitrators and mediators.

Software Program To Increase Efficiency In Image Interpretation

Wednesday, October 20, 2021 - 2:00pm

The software offers a simple and intuitive user interface that users can easily set-up and integrate into their production workflows for automatic processing.

Key Points: 
  • The software offers a simple and intuitive user interface that users can easily set-up and integrate into their production workflows for automatic processing.
  • Users can inspect high volumes of products and increase the reliability of interpretations.
  • This reduces labor costs as defects can be quickly detected and identified by the software and increases throughput and repeatability.
  • This software is compatible with other many image formats and is even compatible with competitive acquisition systems.

U.K. Pharmacovigilance Market 2021-2028: Spontaneous Reporting Holds Largest Share - ResearchAndMarkets.com

Wednesday, October 20, 2021 - 12:48pm

Moreover, the introduction of technologically advanced and user-friendly software systems, such as cloud-based PV platforms, is anticipated to drive the market in the coming years.

Key Points: 
  • Moreover, the introduction of technologically advanced and user-friendly software systems, such as cloud-based PV platforms, is anticipated to drive the market in the coming years.
  • In June 2017, Genpact launched Pharmacovigilance Artificial Intelligence ("PVAI") solution to alter drug safety data management and reporting.
  • An increase in R&D and the adoption of new technologies in clinical research are likely to further drive the market.
  • Some of the data management software include PV-Works Human, ClinSource, and Oracle
    The oncology therapeutic area segment held the largest share of over 25.0% in 2020.

Leading Alternative Dispute Resolution Firm Expands Charlotte Office, Acquiring Four Mediators

Wednesday, October 20, 2021 - 12:00pm

Miles Mediation & Arbitration , the fastest growing alternative dispute resolution (ADR) firm in the Southeast, announces today the expansion of their Charlotte office, acquiring four additional mediators and arbitrators to accommodate every case type, size, and complexity.

Key Points: 
  • Miles Mediation & Arbitration , the fastest growing alternative dispute resolution (ADR) firm in the Southeast, announces today the expansion of their Charlotte office, acquiring four additional mediators and arbitrators to accommodate every case type, size, and complexity.
  • The Miles Charlotte office, the only firm in Charlotte with an office dedicated to alternative dispute resolution, has continued to experience significant growth despite opening in the midst of a pandemic.
  • The firm specializes in mediation, arbitration, and all forms of dispute management, and has a reputation for delivering exceptional client service coupled with successful results.
  • Mediation, arbitration, and dispute management are often a more efficient and economical way to resolve legal and corporate disputes between parties.

Digital Therapeutic MODIA™ Designed to Improve Medication-Assisted Treatment Experience for Opioid Use Disorder

Monday, October 18, 2021 - 4:07pm

The paper outlines the development and features of a new digital therapeutic, MODIA.

Key Points: 
  • The paper outlines the development and features of a new digital therapeutic, MODIA.
  • MODIA was developed in close collaboration with OUD specialists and OUD patients at various stages of recovery.
  • "We know that the ability to combine medication with psychosocial support improves the lives of those struggling with opioid dependence.
  • MODIA is cognitive behavioral therapy (CBT)-based digital therapy that was developed to provide adjunct counseling support.

Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3

Monday, October 18, 2021 - 6:00am

Ipsen (Euronext: IPN; ADR: IPSEY) and Accent Therapeutics (Accent) have signed an exclusive worldwide-collaboration agreement to research, develop, manufacture, and commercialize Accents pre-clinical stage METTL3 program.

Key Points: 
  • Ipsen (Euronext: IPN; ADR: IPSEY) and Accent Therapeutics (Accent) have signed an exclusive worldwide-collaboration agreement to research, develop, manufacture, and commercialize Accents pre-clinical stage METTL3 program.
  • Christelle Huguet, Senior Vice President, Head of Research, External Innovation and Early Development, Ipsen, said Oncology is a key focus area for Ipsen as we grow our pipeline.
  • We are delighted to partner with Accent to progress the METTL3 program as we continue our expansion into hematologic oncology.
  • Accent Therapeutics novel investigational small molecule inhibitors of METTL3 seek to treat specific sub-types of AML with high unmet medical need.